IPA - ImmunoPrecise Antibodies Ltd. Quarterly EPS earnings growth
ARR growth and new contracts for AI protein modeling are driving the development of ImmunoPrecise Antibodies (IPA). Its status as a reliable drug discovery partner is confirmed by recorded quarterly EPS growth, where the metric value stands at 93.60. This trend proves the efficiency of the operating model. High confidence from pharma behemoths in the accuracy of the brand's bioinformatics platforms solidifies the company's role as a leader in IT biotech.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_IPA_-_ImmunoPrecise-Antibodies_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "ImmunoPrecise Antibodies Ltd. (IPA): Quarterly EPS earnings growth from 07/04/2022 to 09/04/2025 | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for ImmunoPrecise Antibodies (IPA)
- market value and analyst target forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Debt to Equity ImmunoPrecise Antibodies|IPA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital immunoprecise.com|IPA - Company Cumulative Debt|Debt to Book Value ImmunoPrecise|IPA - Company Long-Term Loans and Borrowings|Company Short-Term Debts ImmunoPrecise Antibodies|Quick Liquidity immunoprecise.com
- earnings and valuation multiples indicators:
IPA - Company Profit|Future Profit ImmunoPrecise Antibodies|IPA - Market Price to Net Income Ratio|Forward P/E Multiple immunoprecise.com|IPA - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple ImmunoPrecise|IPA - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months ImmunoPrecise Antibodies|IPA - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth immunoprecise.com|IPA - Earnings per share growth this year|Earnings growth forecast for next year ImmunoPrecise Antibodies
Comprehensive company analysis:ImmunoPrecise Antibodies Ltd, IPA
Investors often overvalue biotech startups, yet the fundamental stability of ImmunoPrecise Antibodies (IPA) is based on a steady cash flow from contract antibody development. By analyzing the quarterly EPS growth rate on the GURU.Markets platform, the expert assesses net income per share dynamics, which allows for the separation of temporary market spikes from the business's actual ability to withstand cost inflation and maintain margins.
Who ImmunoPrecise Antibodies competes with
Tempus AI Inc (TEM) - Year-over-year earnings per share growth for the last twelve months|Qiagen NV - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharma) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Repligen Inc. RGEN|Quarterly EPS earnings growth RNA|Year-over-year net earnings per share growth for the last 12 months crisprtx.com CRSP|Quarterly EPS earnings growth WGS (GeneDx)|Year-over-year net earnings per share change for the last twelve months Ultragenyx Pharmaceutical Inc. (RARE)|BEAM - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Sarepta Corp SRPT|TWST: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months 10xgenomics.com (TXG)|Year-over-year net earnings per share growth for the last 12 months NTLA|STOK: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth BLFS|Quarterly EPS earnings growth Wave Pharma (WVE)|Year-over-year earnings per share growth for the last twelve months Maze Therapeutics Inc MAZE|SION: Year-over-year earnings per share growth for the last 12 months|PRME: Year-over-year net earnings per share growth for the last 12 months|Taysha Gene Therapies Inc - Year-over-year earnings per share growth rate for the last twelve months|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|RGNX (REGENXBIO Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months SLDB|Year-over-year earnings per share growth for the last twelve months Ocugen (OCGN)|PACB - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth BNTC (Benitec)|DSGN: Year-over-year earnings per share growth for the last 12 months|Rocket Pharmaceuticals - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months 4dmoleculartherapeutics.com FDMT|LXEO: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Korro Bio (KRRO)|Year-over-year earnings per share growth for the last twelve months Editas|Silence Therapeutics Corp (SLN) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth PRQR|Year-over-year net earnings per share change for the last twelve months codexis.com|Year-over-year earnings per share growth for the last twelve months Sangamo Therapeutics, Inc. SGMO|NAUT (Nautilus Biotechnology, Inc.) - Year-over-year net earnings per share trend for the last twelve months|Metagenomi, Inc - Quarterly EPS earnings growth|DTIL - Quarterly EPS earnings growth|GBIO: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months BOLD|Year-over-year earnings per share growth for the last twelve months Exicure Inc.|Year-over-year earnings per share growth for the last 12 months IMNN (Celsion Corporation)|Quarterly EPS earnings growth PHIO|Quarterly EPS earnings growth mustangbio.com (MBIO)|Quarterly EPS earnings growth RNAZ (TransCode Therapeutics, Inc.)|Year-over-year net earnings per share change for the last twelve months Bionano Genomics Inc. (BNGO)|APDN - Year-over-year earnings per share growth for the last twelve months|bluebird bio Inc. (BLUE) - Year-over-year net earnings per share growth for the last 12 months|Omega (OMGA) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Singular Genomics Corp|Year-over-year net earnings per share growth for the last 12 months RGLS|Quarterly EPS earnings growth syros.com|Year-over-year earnings per share growth for the last twelve months Telesis Bio (TBIO)|TRACON Pharmaceuticals Inc. - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Unity Bio UBX
